Latest Asx News

PEXA Group has dismissed any undisclosed information behind its recent share price drop, attributing market moves to a preliminary IPART pricing consultation paper.

Acrow Limited has reported record new hire contracts and a robust sales pipeline, confirming FY26 guidance and issuing optimistic initial guidance for FY27 revenue and earnings.

CVC Limited has addressed ASX concerns over a delayed Appendix 3Y filing related to director John Leaver’s interest change, attributing the delay to administrative oversight while affirming existing compliance policies.

Dome Gold Mines Ltd launches a $3 million convertible note offering to fund key developments in Fiji, including the Sigatoka Feasibility Study and expanded exploration for copper, gold, and silver.

Lumos Diagnostics has secured its largest-ever order for FebriDx® following FDA clearance, signalling a major expansion in the US market opportunity.

Advanced Innergy Holdings Ltd has responded to ASX inquiries denying any media leak regarding its proposed $0.40 cash bid for Matrix Composites & Engineering, reaffirming its commitment to strict disclosure policies.

Arovella Therapeutics has demonstrated that its novel CLDN18.2-targeting CAR incorporated into iNKT cells effectively eliminates pancreatic and gastric cancer cells in vitro, with IL-12-TM armouring enhancing potency and durability.

Metgasco has ended its asset sale agreement with Vintage Energy after funding conditions were unmet, signaling a strategic pivot amid ongoing exploration and recapitalisation efforts.

Lindian Resources has raised A$100 million through an institutional placement, fully funding its Kangankunde Stage 1 project and accelerating Stage 2 expansion alongside downstream processing integration.

Dateline Resources has bolstered its financial position with a $50 million institutional placement, setting the stage for rapid development of its Colosseum Gold-REE Project in California. The company is on track to complete its Bankable Feasibility Study by April 2026, advancing towards production and project financing.

Asara Resources reports strong drilling results at its Massan deposit within the Kada Gold Project, confirming continuity and extensions of high-grade gold mineralisation. The company advances its resource growth strategy with ongoing drilling and plans for a Mineral Resource Estimate update.

Little Green Pharma has issued a supplementary scheme booklet updating Cannatrek shareholders on the acquisition progress, including a revised timetable and the termination of a planned sale and leaseback of its WA production facility. Both companies’ boards continue to recommend the scheme, supported by an independent expert’s positive assessment.